Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) Net income
Medtronic PLC's net income for fiscal 2026 was $4.8B, unchanged from fiscal 2025. Over the twelve months to 31 July 2026 it was $5.3B. Over the past ten years it has ranged from $2.7B (fiscal 2015) to $5.1B (fiscal 2022); the current reading is higher than 92% of that period. Medtronic PLC ranks 2nd of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $4.8B | 3.11% |
| FY2025 | $4.7B | 26.61% |
| FY2024 | $3.7B | (2.09%) |
| FY2023 | $3.8B | (25.25%) |
| FY2022 | $5.1B | 39.45% |
| FY2021 | $3.6B | (24.47%) |
| FY2020 | $4.8B | 3.35% |
| FY2019 | $4.7B | 50.24% |
| FY2018 | $3.1B | (23.09%) |
| FY2017 | $4.0B | 13.74% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jul 2026 | $1.5B | 17.47% |
| Apr 2026 | $1.3B | 9.48% |
| Jan 2026 | $1.2B | (16.73%) |
| Oct 2025 | $1.4B | 31.90% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| ABT Abbott Laboratories compare | $5.4B |
| MDT Medtronic PLC | $5.3B |
| SYK Stryker Corporation compare | $3.7B |
| BSX Boston Scientific Corporation compare | $3.7B |
| GEHC GE HealthCare Technologies Inc. compare | $2.1B |
| PHG Koninklijke Philips N.V. compare | $1.3B |
| EW Edwards Lifesciences Corporation compare | $1.0B |
| DXCM DexCom, Inc. compare | $999.7M |
| STE STERIS plc compare | $808.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on MDT
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement